
IDEXX Laboratories IDXX
$ 675.24
-2.1%
IDEXX Laboratories EV - Enterprise Value | IDXX
Annual EV - Enterprise Value IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.7 B | 39.1 B | 48.8 B | 44.8 B | 47 B | 45.7 B | 26 B | 19.5 B | 18 B | 12.3 B | 7.93 B | 8.87 B | 6.48 B | 5.53 B | 5.12 B | 1.96 B | 1.48 B | 1.42 B | -60.4 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.7 B | -60.4 M | 20.7 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
184 M | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
35.7 B | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
145 B | $ 220.3 | -3.19 % | $ 157 B | ||
|
DexCom
DXCM
|
28.2 B | $ 79.02 | -1.46 % | $ 30.8 B | ||
|
Anixa Biosciences
ANIX
|
990 K | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Celcuity
CELC
|
5.57 B | $ 53.32 | -5.31 % | $ 2.49 B | ||
|
Guardant Health
GH
|
15.2 B | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
1.01 B | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
463 M | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
23.8 B | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
30.1 B | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 28.63 | -2.22 % | $ 27.1 B | ||
|
Fulgent Genetics
FLGT
|
583 M | $ 24.03 | -3.03 % | $ 740 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 69.9 | -2.81 % | $ 3.72 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Biomerica
BMRA
|
8.91 M | $ 1.09 | -0.46 % | $ 3.18 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 4.4 | -4.35 % | $ 19.5 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 102.12 | 0.01 % | $ 6.89 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 8.03 | -9.88 % | $ 335 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 15.92 | -1.82 % | $ 4.52 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
ICON Public Limited Company
ICLR
|
16.5 B | $ 186.79 | -1.88 % | $ 14.6 B | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 0.13 | -22.11 % | $ 173 K | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 668.26 | -2.95 % | $ 252 B | ||
|
DarioHealth Corp.
DRIO
|
11 M | $ 1.31 | -9.02 % | $ 5.22 M | ||
|
Myriad Genetics
MYGN
|
598 M | $ 5.47 | -1.26 % | $ 507 M | ||
|
Precipio
PRPO
|
42.5 M | $ 17.46 | -5.6 % | $ 28 M | ||
|
ENDRA Life Sciences
NDRA
|
7.31 M | $ 3.58 | -3.38 % | $ 4.74 M | ||
|
QIAGEN N.V.
QGEN
|
-839 M | $ 49.28 | -0.72 % | $ 10.7 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 14.8 | -1.95 % | $ 1.9 B | ||
|
OPKO Health
OPK
|
1.34 B | $ 1.58 | -2.17 % | $ 1.19 B | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.64 | -7.1 % | $ 492 M | ||
|
Neogen Corporation
NEOG
|
3.58 B | $ 10.45 | -3.73 % | $ 2.27 B | ||
|
Personalis
PSNL
|
380 M | $ 14.29 | -2.96 % | $ 1.28 B | ||
|
Quidel Corporation
QDEL
|
460 M | $ 8.31 | -6.84 % | $ 350 M | ||
|
Centogene N.V.
CNTG
|
-8.4 M | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
21.6 B | $ 438.11 | -4.11 % | $ 26.1 B | ||
|
Neuronetics
STIM
|
168 M | $ 1.24 | -4.44 % | $ 81.8 M | ||
|
Trinity Biotech plc
TRIB
|
327 M | $ 6.24 | 13.76 % | $ 2.24 B | ||
|
Exagen
XGN
|
78.4 M | $ 3.59 | -5.53 % | $ 77.4 M |